PlumX Metrics
Embed PlumX Metrics

Solasonine Inhibits Cancer Stemness and Metastasis by Modulating Glucose Metabolism via Wnt/β-Catenin/Snail Pathway in Osteosarcoma

American Journal of Chinese Medicine, ISSN: 1793-6853, Vol: 51, Issue: 5, Page: 1293-1308
2023
  • 10
    Citations
  • 0
    Usage
  • 2
    Captures
  • 2
    Mentions
  • 0
    Social Media
Metric Options:   Counts1 Year3 Year

Metrics Details

Most Recent News

Research Data from Hubei University of Arts & Science Update Understanding of Armadillo Domain Proteins (Solasonine Inhibits Cancer Stemness and Metastasis By Modulating Glucose Metabolism Via Wnt/beta-catenin/snail Pathway In Osteosarcoma)

2023 SEP 12 (NewsRx) -- By a News Reporter-Staff News Editor at NewsRx Life Science Daily -- Current study results on Proteins - Armadillo Domain

Article Description

Solasonine (SS) is a natural glycoalkaloid compound that has been reported to possess a significant anticancer function. However, its anticancer effects and related mechanisms in osteosarcoma (OS) have not been studied. This study sought to investigate the impact of SS on the growth of OS cells. OS cells were treated with different concentrations of SS for 24h, and the results showed that SS attenuated the survival of OS cells in a dose-dependent manner. Additionally, SS suppressed cancer stem-like properties and epithelial-mesenchymal transition (EMT) by inhibiting aerobic glycolysis in OS cells in an ALDOA-dependent manner. Additionally, SS reduced the levels of Wnt3a, β-catenin, and Snail in OS cells in vitro. Furthermore, Wnt3a activation reversed the SS-induced inhibition of glycolysis in OS cells. Collectively, this study discovered a novel effect of SS in inhibiting aerobic glycolysis, in addition to cancer stem-like features and EMT, implying that SS could be a therapeutic candidate for OS treatment.

Bibliographic Details

Provide Feedback

Have ideas for a new metric? Would you like to see something else here?Let us know